Ines Munoz De Laborde, MD
Family Practice · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 22
- 5 carriers
- Office
- 1
Offices
1 location · Center for Cardiovascular Care A Medical Corporation · 11 clinicians in this group
Plans that list them
22 plans · 5 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Laborde’s office at (408) 937-9000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
22 of 22 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A51400 · Current
Licensed to practise in California · since 1992 · expires 2028-02-29 · Complutense University of Madrid Faculty of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$6,095
Medicare paid this office $6,095 for 37 people. Most of that is long return visits and Botox.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Long return visit (40+ min) | 25 | $4,603 | $153 |
| Return visit (30+ min) | 12 | $684 | $53 |
Who their Medicare patients are
37 Original Medicare patients in 2024. Average age 73 · Also on Medicaid 60% · Health risk score 1.07. At or below the middle of the specialty; the typical family practice clinician is at 1.13.
Conditions among them: High blood pressure 75% · Diabetes 57% · Chronic kidney disease 32%.
The office billed $20,070, Medicare allowed $10,052 and paid $6,095; for 56 services of 8 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 37 | 56 | 73 | 1.07 | $20,070 | $6,095 |
| 2023 | 51 | 82 | 71 | 1.53 | $13,719 | $4,159 |
| 2022 | 65 | 88 | 74 | 1.19 | $14,590 | $4,080 |
| 2021 | 75 | 122 | 73 | 1.29 | $13,294 | $6,695 |
| 2020 | 62 | 109 | 71 | 1.15 | $27,800 | $5,467 |
| 2019 | 95 | 206 | 72 | 1.27 | $48,687 | $12,859 |
| 2018 | 94 | 205 | 72 | 1.03 | $28,496 | $11,470 |
| 2017 | 89 | 183 | 74 | 1.20 | $29,973 | $10,522 |
| 2015 | 70 | 134 | 69 | 0.84 | $17,695 | $5,260 |
| 2014 | 159 | 284 | 70 | 0.85 | $40,288 | $13,143 |
| 2013 | 133 | 248 | 69 | 0.81 | $29,119 | $12,833 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 3 services
| Short return visit (20+ min) | 20 | $1,934 | $74 |
| New patient visit (15+ min) | 24 | $962 | $40 |
| Urinalysis, manual test | 12 | $45 | $3 |
2022: 2 services
| New patient visit (15+ min) | 37 | $2,006 | $54 |
| Short return visit (20+ min) | 24 | $1,462 | $58 |
2021: 2 services
| Short return visit (20+ min) | 24 | $2,221 | $69 |
| New patient visit (15+ min) | 41 | $2,015 | $49 |
2020: 3 services
| Short return visit (20+ min) | 17 | $1,671 | $62 |
| New patient visit (15+ min) | 23 | $1,403 | $61 |
| New patient visit (30+ min) | 18 | $935 | $52 |
2019: 3 services
| Return visit (30+ min) | 34 | $5,118 | $90 |
| New patient visit (30+ min) | 53 | $4,061 | $77 |
| New patient visit (45+ min) | 11 | $1,101 | $100 |
2018: 2 services
| Return visit (30+ min) | 33 | $4,655 | $88 |
| New patient visit (30+ min) | 54 | $3,910 | $72 |
2017: 2 services
| New patient visit (30+ min) | 55 | $4,811 | $87 |
| Return visit (30+ min) | 29 | $2,841 | $81 |
2015: 2 services
| Return visit (30+ min) | 30 | $2,135 | $65 |
| New patient visit (30+ min) | 29 | $1,717 | $59 |
2014: 3 services
| Return visit (30+ min) | 71 | $5,693 | $66 |
| New patient visit (30+ min) | 63 | $4,118 | $65 |
| Automated urinalysis test | 22 | $72 | $3 |
2013: 5 services
| Return visit (30+ min) | 57 | $5,890 | $84 |
| New patient visit (30+ min) | 61 | $4,351 | $71 |
| Administration of influenza virus vaccine | 11 | $299 | $27 |
| Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval) | 11 | $94 | $9 |
| Automated urinalysis test | 14 | $52 | $3 |
Medicaid work
$0 in 2024
Medicaid paid $0 for 287 billed services this clinician did in 2024, up to 40 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| New patient visit (30+ min) | 16 | $0 |
| Return visit (30+ min) | 180 | $0 |
| Long return visit (40+ min) | 91 | $0 |
| 2024 | 287 | 3 | 40 | $0 |
| 2023 | 631 | 5 | 56 | $443 |
| 2022 | 542 | 3 | 52 | $993 |
| 2021 | 728 | 4 | 54 | $1,585 |
| 2020 | 676 | 7 | 73 | $236 |
| 2019 | 1,387 | 3 | 86 | $399 |
| 2018 | 1,260 | 9 | 71 | $1,482 |
See the largest Medicaid services in earlier years
2023
| OFFICE/OUTPATIENT NEW SF MDM 15 MINUTES | 237 | $237 |
| Short return visit (20+ min) | 273 | $135 |
| New patient visit (30+ min) | 74 | $63 |
| Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; Streptococcus, group A | 12 | $8 |
| Short return visit | 35 | $0 |
2022
| OFFICE/OUTPATIENT NEW SF MDM 15 MINUTES | 251 | $582 |
| New patient visit (30+ min) | 47 | $252 |
| Short return visit (20+ min) | 244 | $159 |
2021
| OFFICE/OUTPATIENT NEW SF MDM 15 MINUTES | 399 | $1,407 |
| Short return visit (20+ min) | 263 | $158 |
| Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; Streptococcus, group A | 54 | $19 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; non-automated, without microscopy | 12 | $0 |
2020
| New patient visit (30+ min) | 118 | $137 |
| OFFICE/OUTPATIENT NEW SF MDM 15 MINUTES | 223 | $72 |
| Short return visit (20+ min) | 189 | $26 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; non-automated, without microscopy | 27 | $0 |
| URINALYSIS | 13 | $0 |
| Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; Streptococcus, group A | 44 | $0 |
| Return visit (30+ min) | 62 | $0 |
2019
| New patient visit (30+ min) | 766 | $241 |
| Return visit (30+ min) | 480 | $157 |
| Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; Streptococcus, group A | 141 | $1 |
2018
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 13 | $336 |
| DIPHTH TETANUS TOX ACELL PERTUSSIS VACC<7 YR IM | 30 | $298 |
| Return visit (30+ min) | 316 | $294 |
| Poliovirus vaccine, inactivated (IPV), for subcutaneous or intramuscular use | 18 | $179 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 12 | $135 |
| New patient visit (30+ min) | 689 | $122 |
| Haemophilus influenzae type b vaccine (Hib), PRP-T conjugate, 4 dose schedule, for intramuscular use | 12 | $119 |
| Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; Streptococcus, group A | 127 | $0 |
| Short return visit (20+ min) | 43 | $0 |
Drugs they prescribed that Part D paid
$69,606
Pharmacies billed $69,606 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
478 generic and fewer than 11 brand-name prescriptions · $69,606 in drug cost · 13 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Jardiance | 20 | $25,970 | $1,299 |
| Ozempic | 11 | $14,919 | $1,356 |
| Atorvastatin | 75 | $479 | $6 |
| Sumatriptan | 12 | $362 | $30 |
| Levothyroxine | 20 | $358 | $18 |
See all 12 drugs
| Jardiance | 20 | $25,970 | $1,299 |
| Ozempic | 11 | $14,919 | $1,356 |
| Atorvastatin | 75 | $479 | $6 |
| Sumatriptan | 12 | $362 | $30 |
| Levothyroxine | 20 | $358 | $18 |
| Amlodipine Besylate | 36 | $184 | $5 |
| Losartan | 32 | $156 | $5 |
| Metformin | 37 | $122 | $3 |
| Metoprolol | 11 | $100 | $9 |
| Lisinopril | 18 | $90 | $5 |
| Losartan-Hydrochlorothiazide | 13 | $68 | $5 |
| Omeprazole | 17 | $22 | $1 |
Year by year
| 2024 | 568 | 156 | None | None | $69,606 |
| 2023 | 222 | 155 | 0% (0) | 8% | $5,367 |
| 2022 | 177 | 129 | 0% (0) | None | $6,529 |
| 2021 | 226 | 156 | 0% (0) | None | $3,013 |
| 2020 | 218 | 136 | 0% (0) | None | $5,713 |
| 2019 | 287 | 197 | 0% (0) | 8% | $4,815 |
| 2018 | 248 | 176 | None | None | $4,707 |
| 2017 | 264 | 164 | None | 12% | $5,833 |
| 2016 | 255 | 150 | 0% (0) | None | $4,783 |
| 2015 | 92 | 56 | None | None | $2,011 |
| 2014 | 81 | 48 | 0% (0) | None | $1,810 |
| 2013 | 104 | 54 | None | None | $2,284 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 8 drugs
| Albuterol Sulfate Hfa | 11 | $335 | $30 |
| Nitrofurantoin Mono-Macro | 12 | $175 | $15 |
| Sulindac | 15 | $143 | $10 |
| Amoxicillin | 13 | $94 | $7 |
| Ciprofloxacin | 17 | $93 | $5 |
| Azithromycin | 15 | $92 | $6 |
| Cephalexin | 16 | $77 | $5 |
| Cyclobenzaprine | 11 | $34 | $3 |
2022: 4 drugs
| Permethrin | 17 | $1,083 | $64 |
| Cephalexin | 12 | $74 | $6 |
| Cyclobenzaprine | 16 | $70 | $4 |
| Ciprofloxacin | 12 | $54 | $4 |
2021: 6 drugs
| Azithromycin | 14 | $112 | $8 |
| Cephalexin | 16 | $100 | $6 |
| Cyclobenzaprine | 17 | $63 | $4 |
| Meclizine | 11 | $50 | $5 |
| Naproxen | 17 | $49 | $3 |
| Ciprofloxacin | 17 | $45 | $3 |
2020: 4 drugs
| Albuterol Sulfate Hfa | 14 | $557 | $40 |
| Sulindac | 12 | $116 | $10 |
| Azithromycin | 16 | $109 | $7 |
| Cephalexin | 14 | $67 | $5 |
2019: 6 drugs
| Azithromycin | 27 | $208 | $8 |
| Cephalexin | 21 | $111 | $5 |
| Gentamicin Sulfate | 11 | $90 | $8 |
| Ciprofloxacin | 13 | $60 | $5 |
| Levofloxacin | 12 | $55 | $5 |
| Prednisone | 13 | $42 | $3 |
2018: 6 drugs
| Ventolin Hfa | 11 | $608 | $55 |
| Azithromycin | 25 | $204 | $8 |
| Levofloxacin | 25 | $172 | $7 |
| Ciprofloxacin | 17 | $89 | $5 |
| Prednisone | 12 | $53 | $4 |
| Naproxen | 13 | $47 | $4 |
2017: 6 drugs
| Ventolin Hfa | 13 | $702 | $54 |
| Levofloxacin | 36 | $198 | $5 |
| Ciprofloxacin | 21 | $109 | $5 |
| Cephalexin | 15 | $101 | $7 |
| Azithromycin | 12 | $93 | $8 |
| Naproxen | 15 | $52 | $3 |
2016: 6 drugs
| Proair Hfa | 11 | $609 | $55 |
| Levofloxacin | 27 | $195 | $7 |
| Azithromycin | 19 | $173 | $9 |
| Ciprofloxacin | 21 | $99 | $5 |
| Cephalexin | 17 | $82 | $5 |
| Naproxen | 21 | $71 | $3 |
2015: 1 drug
| Azithromycin | 14 | $91 | $7 |
2014: 2 drugs
| Azithromycin | 15 | $148 | $10 |
| Mupirocin | 11 | $116 | $11 |
2013: 2 drugs
| Mupirocin | 13 | $154 | $12 |
| Azithromycin | 11 | $116 | $11 |
Money from drug and device companies
$16 in 2019
A payment is not proof that care is biased.
| GlaxoSmithKline | Shingrix | $16 | 1 payment
|
See the published payment
| GlaxoSmithKline | Meals · 2019-11-09 | Shingrix | $16 |
Professional record
- NPI
- 1912900796
- Licence
- CA A51400California A51400: Current · expires 2028-02-29
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- General practice (208D00000X)
- Mailing address
- 100 Wilson Rd, 100, Monterey, CA, 93940
- NPI first listed
- 2005-05-24
- NPI last updated
- 2011-01-19
This is when the NPI record was last certified, not a medical board exam.